Ettore Novellino
Ettore Novellino
Verified email at
Cited by
Cited by
Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation …
J Bousquet, HJ Schünemann, A Togias, C Bachert, M Erhola, PW Hellings, ...
Journal of Allergy and Clinical Immunology 145 (1), 70-80. e3, 2020
The therapeutic potential of apigenin
B Salehi, A Venditti, M Sharifi-Rad, D Kręgiel, J Sharifi-Rad, A Durazzo, ...
International journal of molecular sciences 20 (6), 1305, 2019
Topological characterization of nucleic acid G‐quadruplexes by UV absorption and circular dichroism
AI Karsisiotis, NM Hessari, E Novellino, GP Spada, A Randazzo, ...
Angewandte Chemie International Edition 50 (45), 10645-10648, 2011
Polyphenols: A concise overview on the chemistry, occurrence, and human health
A Durazzo, M Lucarini, EB Souto, C Cicala, E Caiazzo, AA Izzo, ...
Phytotherapy Research 33 (9), 2221-2243, 2019
Nutraceutical potential and antioxidant benefits of red pitaya (Hylocereus polyrhizus) extracts
GC Tenore, E Novellino, A Basile
Journal of functional foods 4 (1), 129-136, 2012
High-resolution structures of two complexes between thrombin and thrombin-binding aptamer shed light on the role of cations in the aptamer inhibitory activity
I Russo Krauss, A Merlino, A Randazzo, E Novellino, L Mazzarella, F Sica
Nucleic acids research 40 (16), 8119-8128, 2012
To each his own: isonitriles for all flavors. Functionalized isocyanides as valuable tools in organic synthesis
M Giustiniano, A Basso, V Mercalli, A Massarotti, E Novellino, GC Tron, ...
Chemical Society Reviews 46 (5), 1295-1357, 2017
Geometrically and conformationally restrained cinnamoyl compounds as inhibitors of HIV-1 integrase: synthesis, biological evaluation, and molecular modeling
M Artico, R Di Santo, R Costi, E Novellino, G Greco, S Massa, ...
Journal of Medicinal Chemistry 41 (21), 3948-3960, 1998
New α-(N)-heterocyclichydrazones: evaluation of anticancer, anti-HIV and antimicrobial activity
L Savini, L Chiasserini, V Travagli, C Pellerano, E Novellino, S Cosentino, ...
European journal of medicinal chemistry 39 (2), 113-122, 2004
Nutraceuticals: Opening the debate for a regulatory framework
A Santini, SM Cammarata, G Capone, A Ianaro, GC Tenore, L Pani, ...
British journal of clinical pharmacology 84 (4), 659-672, 2018
Nutraceuticals: A paradigm of proactive medicine
A Santini, GC Tenore, E Novellino
European Journal of Pharmaceutical Sciences 96, 53-61, 2017
Molecular basis of cyclooxygenase enzymes (COXs) selective inhibition
V Limongelli, M Bonomi, L Marinelli, FL Gervasio, A Cavalli, E Novellino, ...
Proceedings of the National Academy of Sciences 107 (12), 5411-5416, 2010
Arylthioindole inhibitors of tubulin polymerization. 3. Biological evaluation, structure− activity relationships and molecular modeling studies
G La Regina, MC Edler, A Brancale, S Kandil, A Coluccia, F Piscitelli, ...
Journal of medicinal chemistry 50 (12), 2865-2874, 2007
Specific targeting of acetylcholinesterase and butyrylcholinesterase recognition sites. Rational design of novel, selective, and highly potent cholinesterase inhibitors
L Savini, A Gaeta, C Fattorusso, B Catalanotti, G Campiani, L Chiasserini, ...
Journal of medicinal chemistry 46 (1), 1-4, 2003
Design, molecular modeling, synthesis, and anti-HIV-1 activity of new indolyl aryl sulfones. Novel derivatives of the indole-2-carboxamide
R Ragno, A Coluccia, G La Regina, G De Martino, F Piscitelli, ...
Journal of medicinal chemistry 49 (11), 3172-3184, 2006
Toward a quantitative comparative toxicology of organic compounds
C Hansch, D Kim, AJ Leo, E Novellino, C Silipo, A Vittoria, JA Bond, ...
CRC critical reviews in toxicology 19 (3), 185-226, 1989
Non-nucleoside HIV-1 reverse transcriptase (RT) inhibitors: past, present, and future perspectives
G Campiani, A Ramunno, G Maga, V Nacci, C Fattorusso, B Catalanotti, ...
Current pharmaceutical design 8 (8), 615-657, 2002
Docking Studies on αvβ3 Integrin Ligands:  Pharmacophore Refinement and Implications for Drug Design
L Marinelli, A Lavecchia, KE Gottschalk, E Novellino, H Kessler
Journal of medicinal chemistry 46 (21), 4393-4404, 2003
5-Alkyl-2-(alkylthio)-6-(2,6-dihalophenylmethyl)-3,4-dihydropyrimidin-4(3H)-ones:  Novel Potent and Selective Dihydro-alkoxy-benzyl-oxopyrimidine Derivatives
A Mai, M Artico, G Sbardella, S Massa, E Novellino, G Greco, AG Loi, ...
Journal of medicinal chemistry 42 (4), 619-627, 1999
From pharmaceuticals to nutraceuticals: Bridging disease prevention and management
P Daliu, A Santini, E Novellino
Expert Review of Clinical Pharmacology 12 (1), 1-7, 2019
The system can't perform the operation now. Try again later.
Articles 1–20